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 Lung transplant surgery saves the recipient from the brink of death. However, both the 
surgery and rehabilitation can be risky, complicated and grueling. One must adhere to an 
extensive regimen of expensive (and harmful) immunosuppressive drugs to keep the new lungs 
from being rejected, risk life-threatening infections due to their suppressed immune system, and 
face the reality of a limited life expectancy (the current survival rate at five years is 45%). 
There is a lack of psychosocial, qualitative research on this subject as well as very limited 
data on employment statistics, although it appears that the majority of recipients do not return to 
work. This literature review examines relevant print and online materials regarding the process 
lung transplant recipients experience, and makes recommendations for further research – 
especially qualitative research regarding vocational rehabilitation. 
 
iii 
ACKNOWLEDGMENTS 
 
To Judith: Thank you for the inspiration. God bless you. 
To my research advisor, Dr. Robert Peters: Sincere gratitude and appreciation for your 
exemplary longsuffering, patience, advice and support. 
To Nancy: Your never-ending support and encouragement means more than words can say. 
To my friends, colleagues, and professors at Stout (Drs. Ellie Emanuel, Michelle Hamilton, Tom 
Modahl, Shirley Stewart): Thank you for believing that I could do it (eventually)! 
To Dr. Gary Remafedi: Your support and flexibility is greatly appreciated and will always be 
remembered.
 
iv 
TABLE OF CONTENTS 
…………………………………………………………………………………………………Page 
ABSTRACT………………………………………………………………………………………ii 
CHAPTER I: RATIONALE FOR LITERATURE REVIEW…………………………………….1 
Introduction………………………………………………………………………………………..1 
Definition of Terms………………………………………………………………………………..4 
CHAPTER II: DISCUSSION OF THE LITERATURE……………………………………...…..6 
Types of Literature………………………………………………………………………………...6 
Organization of Literature…………………………………………………………………………6 
CHAPTER III: REVIEW OF THE LITERATURE………………………………………………7 
Background and Status…………………………………………………………………………....7 
Phases of the Lung Transplant Process……………………………………………………………8 
Determining Eligibility……………………………………………………………………………8 
The Wait………………………………………………………………………………………….13 
The Call………………………………………………………………………………….……….17 
Perioperative Recovery…………………………………………………………………………..17 
Posttransplant…………………………………………………………………………………….19 
Long Range Outlook…………………………………………………………………….……….25 
Employment………………………………………………………………………..…………….26 
Uniqueness of Lung Transplant………………………………………………………………….29 
CHAPTER IV: SUMMARY & CONCLUSIONS………………………………………………31 
CHAPTER V: RECOMMENDATIONS………………………...………………………………33 
References…………………….………………………………………………………………….36 
 
v 
Appendix A: Lung Transplant Recipient Survey………………...……………………………....42 
Appendix B: Care Provider for Lung Transplant Recipient Survey..….…………...……………45
 
1 
CHAPTER 1: RATIONALE FOR LITERATURE REVIEW 
Introduction 
Have you ever been unable to breathe? Do you remember the panic you felt when you 
couldn’t draw air into your lungs? Or have you ever been so out of breath from exertion that all 
you could physically manage was to double over and gasp for air? Now imagine being in that 
condition twenty-four hours a day, and we may have just a glimpse of what it is like for persons 
with end-stage lung disease. Their only hope for a fresh breath of life is a lung transplant. 
Lung transplant surgery saves the recipient from the brink of death. However, it is a 
risky, complicated, expensive procedure. Both the surgery and rehabilitation can be grueling for 
the person. One must adhere to an extensive regimen of expensive (and harmful) 
immunosuppressive  drugs to keep the new lungs from being rejected, risk life-threatening 
infections due to their suppressed immune system, and face the reality of a limited life 
expectancy. Current survival rates (as of 03/19/04) for deceased donor transplants are 78% for 
one year, 59% for three years, and 45% for five years (United Network for Organ Sharing 
[UNOS], 2003 Annual Report). This new life comes at a price.  
It was the observation of one researcher (Festle, 2002) that articles in medical journals 
seem to be written in part to justify lung transplantation. With any new treatment, and especially 
one with the risk, complications and limited outcomes of lung transplant, patients and medical 
providers alike need to ask, “Is it worth it – is the ordeal of surgery and the qualify of life after 
surgery worth the price?”  It seems reasonable then, that Festle (2002) quotes the researchers 
from the University of Minnesota: “Quality of life is an important outcome to measure when 
assessing the utility of costly and innovative therapies” (p. 63). 
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There is an emerging body of work that assesses Quality of Life (QOL) for lung 
transplant recipients, most of which is quantitative. There is a small body of qualitative studies, 
the most notable being Qualifying the Quantifying: Assessing the Quality of Life of Lung 
Transplant Recipients (Festle, 2002). Festle argues that asking open-ended questions in the 
process of collecting oral histories obtains “clearer, subtler, and fuller explanations than 
quantitative data permits. People define themselves by more than their diseases, but too often the 
need to address medical crises mean that much of patients’ humanity is lost, and they feel 
objectified” (p.85). Open-ended questions can reveal what someone means when they identify 
their QOL as an 8 on a 10-point scale. Rather than responding to pre-determined categories and 
definitions, allowing for open-ended responses gives recipients the opportunity to provide their 
own definitions of quality of life, assign their own values, and indicate their primary areas of 
need. While one lung transplant recipient may be frustrated most that they cannot work full time, 
another’s priority may simply be that they are alive and have the ability to move without 
supplemental oxygen. 
A life-changing event, such as a life-saving lung transplant, has the potential to generate a 
shift or change in a person’s life priorities. Very often the ability to work is considered a 
component or domain of quality of life, and QOL studies can help discover how the desire to 
enter the workforce after lung transplantation fits into the recipient’s value system and priorities. 
One can also get a picture of how posttransplant complications affect all aspects of the 
recipient’s life; physical as well as social, vocational, and emotional. 
The research data with regard to vocational rehabilitation is very limited, perhaps because lung 
transplantation is a relatively recent procedure. Also, this author’s attempt at conducting a survey 
of lung transplant recipients proved to be lengthy and difficult. Accessing the medical 
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community and obtaining the transplant center’s Institutional Review Board (IRB) approval to 
conduct the survey was a lengthy process. In addition, with Health Insurance Portability and 
Accountability Act (HIPAA) regulations, it is not possible to obtain a mailing list of transplant 
recipients, or request that a survey be sent to a mailing list. In this instance, the only way to 
conduct a study was to “piggyback” a survey along with individual “anniversary” surveys sent 
by the transplant center. To follow this medical center’s protocol and collect enough data to be 
statistically significant would have taken a full year after their IRB approval. Therefore, the time 
required to conduct this research by a party outside the medical center proved to be a significant 
barrier. 
Another possibility for the lack of vocational rehabilitation data for this population is the 
limited life expectancy. The bulk of the literature deals with medical aspects of rehabilitation, not 
social/vocational rehabilitation, and the majority of the research is quantitative. However, as the 
outcomes of lung transplantation improve, the social rehabilitation of lung transplant recipients 
becomes increasingly important. 
Since lung transplant surgery has only been an option since 1986, persons with lung 
transplant are a fairly new population in vocational rehabilitation. Although return-to-work rates 
have been published for recipients of other organ transplants, very limited data are available after 
lung transplantation (Festle, 2002; Paris, et. al, 1998).  
With the growing number of successful surgeries and increased longevity due to medical 
advancements, it is expected that this population will grow. Even at the current rate, with just 
over 1,000 surgeries per year with a 78% survival at one year post-surgery, and 59% survival 
past 3 years (UNOS, 2003 Annual Report), this means there is an existing lung transplant 
population with at least the potential for vocational rehabilitation. At the end of 2002, there were 
 
4 
4,574 persons living with a functioning lung transplant (UNOS, 2003). Therefore, the purpose of 
this literature review is to examine existing literature on the experience of persons receiving lung 
transplant, including any reference to post-operative employment or employment data. It will 
also attempt to review any discussion of lung transplant recipient’s posttransplant values, 
priorities, and perspectives regarding employment. The more information gathered, and the more 
we learn and understand about the individual’s experience, the better equipped medical and 
rehabilitation providers are to provide quality care and services. This review is intended to add to 
the body of research on this subject. 
Definition of Terms 
Sources: UNOS Glossary (http://www.unos.org/resources/glossary.asp), and 
MEDLINEplus (http://www.nlm.nih.gov/medlineplus/encyclopedia.html). 
Acute Rejection: The body's attempt to destroy the transplanted organ; usually occurs in 
the first year after transplant.  
Allograft (or “graft”): An organ or tissue that is transplanted from one person to another. 
In this paper, graft/allograft refers to a transplanted lung or lungs. 
Antiinfectives: Medications used to counter balance the effect of immunosuppressant 
drugs by helping the body fight infection. 
Bronchiolitis obliterans: Also referred to in the literature as chronic rejection, this is 
inflammation and fibrosis of the bronchioles (small passages in the lungs) which 
generally causes an irreversible decrease in pulmonary function. This leads to 
deterioration and eventually death. If this cannot be managed by adjusting/adding 
immunosuppressive therapies, retransplantation may be considered. 
Chronic Rejection: Slow, continuous failure of the transplanted organ. 
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Cytomegalovirus (CMV): Virus that affects an immunocompromised host, such as those 
with HIV/AIDS or organ transplant on immunosuppressive treatment. CMV pneumonia 
in lung transplant recipients is the direct result of immunosuppressive drugs, and can be 
life threatening, depending on the strength of the individual’s immune system. 
Immunosuppressives: Drugs required after surgery to prevent the body’s immune 
response from rejecting and attacking the new organ as “foreign.” The challenge is to 
keep the level of immunosuppressive drugs out of the deadly poison range. 
Living Donor: In lung transplantation, two living adult donors each contribute a lobe 
from one lung to provide two lobes for a smaller recipient. Living donation permanently 
reduces the donor’s vital lung capacity by 15%. A very new procedure, of the 956 lung 
transplants performed in the U.S. in 2000, just 15 came from living donors (Grady, 
2002). Most living donor recipients have cystic fibrosis. 
Rejection: Rejection occurs when the body tries to attack a transplanted organ because it 
reacts to the organ or tissue as a foreign object and produces antibodies to destroy it. 
Anti-rejection (immunosuppressive) drugs help prevent rejection. 
United Network for Organ Sharing (UNOS): Administers the Organ Procurement and 
Transplantation Network, which facilitates organ matching and placement, develops 
organ transplantation policy, and collects and manages data about every transplant event 
in the U.S. Available via the World Wide Web at http://www.unos.org.  
 
6 
CHAPTER 2: DISCUSSION OF THE LITERATURE 
Types of Literature 
The literature reviewed includes everything this author could access in print and online 
on the subject relevant to the subject of the experience of lung transplant recipients. This 
includes newspaper, magazine and journal articles, books, and online resources, such as 
MEDLINEplus, and the Second Wind Web site – an online resource for lung transplant 
candidates and recipients – available at http://www.secondwindstl.org. The primary resource for 
lung transplant data is the UNOS Web site (http://www.unos.org), including the 2003 Annual 
Report. 
Organization of Literature 
The focus of the presentation of the literature is to give as comprehensive an overview as 
possible of the experience of persons awaiting, experiencing, and surviving lung transplant 
surgery. Therefore, the literature is presented in a chronological order, following the process of 
those who have had this experience. After an introduction, which includes an overview 
(background, current status, and demographics), the literature review is intended to paint an in-
depth picture of the process lung transplant recipients experience. Discussion of the long range 
outlook for recipients will follow, including the latest medical and procedural changes with a eye 
towards the future. Review of the literature regarding employment after lung transplant will 
follow. Uniqueness of lung transplant as well as commonalties with other solid organ transplant 
will be discussed. 
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CHAPTER 3: REVIEW OF THE LITERATURE 
Background and Status 
The first successful double-lung transplant surgery was performed at Toronto General 
Hospital in 1986 (Canadian Medical Association Journal, 2001). Lung transplantation is a 
relatively new surgical procedure, and approximately seventy medical centers in the U.S. 
perform this operation (UNOS, 2003). Of these, ten medical centers performed thirty or more 
lung transplants in 2000 (Barzoloski-O’Connor, 2002). The number of people receiving lung 
transplants has steadily increased; the majority of recipients have been 35-64 years of age (Smith 
S., 2002). More than 10,000 lung transplant procedures have been performed worldwide, and 
have averaged between 1300 and 1400 per year, with 65% of these performed in the United 
States (Maurer, 2001). In 1993, there were 667 lung transplants performed in the U.S.; eight 
years later, in 2001, there were 1,054 lung transplants, and 1,041 recipients in 2002. Most of 
these transplants are from deceased donors; approximately 20 recipients per year receive lung 
lobes from living donors. As of March 19, 2004, the number of people on the UNOS lung 
transplant waiting list was 3,914 persons (UNOS, 2003). 
Lung transplant is a lifesaver – but only temporarily. The national rates according to the 
United Network for Organ Sharing Web site (UNOS, 2003 Annual Report) for postoperative 
survival of deceased donor transplants is 78% for one year, 59% for three years, and 45% for 
five years. Three-year survival rates for living donor recipients are lower (42%). There are 
exceptions; the first successful double-lung transplant recipient lived for 15 years after her 
surgery in 1986, and she died of a brain aneurysm (Canadian Medical Association Journal, 
2001). The longest surviving double-lung transplant recipient has been post-transplant for over 
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17 years (UNOS 2003 data). However, these are exceptions; the medical reality is that, in 
essence, the recipient knows that they are buying themselves just a little more time to live. The 
leading cause of postoperative lung transplant mortality is chronic rejection and is the major 
hurdle limiting long-term survival (Lau & Patterson, 2003); more than 70% of patients 
eventually develop bronchiolitis obliterans (Wunsch, 1999). Survival rates are slowly improving; 
death rates in the overall recipient population decreased over the ten years reported (UNOS 2003 
Annual Report). 
Demographic data from 2001-2003 show the majority of lung transplant recipients as 
white (87%), with 7% Black, 4% Hispanic, 1% Asian, and 1% Other/Multicultural. There is an 
approximately equal distribution between male and female recipients, and the data suggests a rise 
in the proportion of recipients older than 50 years of age; 57% of recipients from 2001-2003 
were between 50-64 years of age (UNOS, 2003).  
Phases of the Lung Transplant Process 
Determining Eligibility for the UNOS Lung Transplant Waiting List 
Evaluation. End stage lung disease is the essential criteria to qualify a person for the lung 
transplant waiting list. Also, the prognosis for the individual must be that they are strong enough 
to survive the surgery (Maurer, 2001). Those with either emphysema or cystic fibrosis comprise 
the majority of lung transplant recipients (Key & Lindgren, 1999; Liou, et al., 2001; UNOS, 
2003). The typical lung transplant candidate has a life expectancy of less than 18 months, is 
dependent on supplemental oxygen, and is under age 65. The majority of lung transplant patients 
have been 35-64 years of age (Smith. S., 2002). 
The process of patient eligibility for the UNOS waiting list varies considerably from 
center to center, particularly in terms of considering psychological and psychosocial factors 
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(Dew, et al., 2002; Olbrisch, Benedict, Ashe & Levenson, 2002). The transplant evaluation 
consists of a series of tests, procedures, and assessments that usually take 3-5 days to complete. 
The results are compiled and the multidisciplinary transplant team reviews the information. 
Expectations of a poor survival outcome because of medical, psychosocial, or financial reasons 
are the major contraindications to listing a patient eligible for transplantation (Smith, S., 2002). 
For example, the Fairview University Medical Center (which is associated with the University of 
Minnesota) has a mandatory smoking cessation program for recent smokers, which includes a 
signed contract, documented 4-month compliance, and random urine samples. Their policy states 
that “Due to the limited supply of donor organs, it is crucial to allocate the organs to those 
patients who are expected to have optimal outcomes” (Hertz, 2001, p.16).  
Other examples of likely contraindications which may disqualify a candidate:  
Medical – heart disease, diabetes, history of cancer, obesity, Hepatitis-C; current alcohol/drug 
abuse; Financial – inadequate financial resources to obtain immunosuppressive medications 
posttransplant; Cognitive/Psychosocial – Inability to understand the procedure, risks involved, or 
comply with follow-up care; psychiatric illness; inadequate support system to assist in both 
pretransplant and posttransplant care (Hertz, 2001).  
In addition, transplant centers require that candidates live from thirty minutes to two 
hours away from the center (Barzoloski-O’Connor, 2002; Newman, 1999; Tomb, 2002). For 
many, this requires pulling up stakes and moving close to a transplant center. 
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Psychosocial Aspects. The patients undergoing evaluation are nearing the end of a long 
road of coping with deteriorating health. The majority of patients and their families experience 
conflicting feelings: 
• Anxiety about being accepted as a candidate (and being judged physically and 
psychologically), and eagerness to move forward, 
• Daring to hope for a healthy future, combined with fear about the surgery and the 
possibility the transplant will fail,  
• What it will be like to have someone else’s organ, 
• Worries that an organ won’t be available in time (Dew, et al., 2002). 
Also, there is likely to be concern with financial issues: payment for procedures and 
medications, disability status, insurance coverage, and the potential need to relocate near the 
transplant center. Even with good insurance benefits, expenses for travel, relocating and time lost 
from work may be a significant economic burden (Dew, et al., 2002). One applicant was told he 
was not yet at “end stage” development. He was told to either retire from his job if possible, or 
change his work situation to reduce the stress on his body – with the goal being survival until he 
had reached “end stage” in order to qualify for the waiting list (Tunison, 2002). In this case, the 
applicant most likely had to take on financial stress as part of the qualifying process. 
In addition to sharing the above concerns, caregivers may experience anxiety about 
whether they will be perceived as capable and helpful to the patient. A common concern is 
wondering if they are up to the task – or have the expertise to care for the patient posttransplant 
(Dew, et al., 2002). 
Ethical Issues. The issue of whether patients should be excluded from transplantation on 
the basis of psychological and psychosocial criteria is controversial in the transplant and medical 
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ethics communities. Moral and ethical issues arise when transplantation is offered on the basis of 
psychosocial and behavioral history and/or status. If a behavior or psychosocial status is a 
criterion for eligibility, great care needs to be taken in its assessment and evaluation. Some 
programs provide referrals for applicants that need psychosocial interventions, others only 
identify those who should be excluded as candidates (Dew, et al., 2002). 
In the mid-90s, there were three well publicized cases of people with Down’s Syndrome 
who were denied eligibility for the waiting list based on their disability (Sandra Jensen, US; 
Terry Urquhart, Canada; Jo Harris, Great Britain). Sandra Jensen’s case prompted California 
legislation that prohibits discrimination against people with disabilities who need transplants 
(New York Times, 1997), and media attention in Canada pressured the University of Alberta’s 
decision to reverse Terry Urquhart’s eligibility denial (Maclean’s, 1995). Despite media 
publicity, it appears that the eligibility status for Jo Harris did not change (Sommerville, 1996). 
It was reported in 2001 that surgeons in Melbourne, Australia were refusing to provide 
heart and lung transplants to smokers. The Australian Medical Association said it was 
“unconscionable” for a surgeon to take a moral stand on treating a patient. Ethicists said it was 
discriminatory because lifestyle could be blamed for illnesses such as obesity and some types of 
cancer (Jauhar, 2003). However, it appears that the 4-month smoking ban at Fairview University 
Medical Center is based on likelihood of optimal medical outcomes, not a moral judgement. The 
center’s policy addresses the ethical issues of this policy by stating that patients have a 
responsibility to help themselves achieve the greatest possible success. In addition, “medical 
professionals feel a strong responsibility to organ donors and their families, and it is our 
obligation to ensure that high-risk behaviors are eliminated prior to transplantation” (Hertz, 
2001, p. 16). 
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Generally, applicants over age 65 are not eligible; however, this is usually determined on 
an individual basis (Smith, S., 2002). Although some carefully selected elderly patients have 
been demonstrated to have outcomes comparable to younger patients, this is still subject to the 
policy and discretion of the transplant center and transplant team (Dew, et al., 2002; Olbrisch, et. 
al., 2002). 
What is underneath all this controversy of eligibility is the fact that there are not enough 
healthy lungs available for the people who need them. Scarcity of organs and suboptimal 
recipient survival underscores the critical factor of the process of selection. Mauer’s JAMA 
editorial (2001) illustrates the difficulties and medical complexities in “identifying more 
precisely those patients who can optimally benefit from lung transplant,” (p.2721) and challenges 
clinicians to determine models that do a better job of this. Ann Sommerville, head of medical 
ethics, British Medical Association, writes about the sad reality that some applicants will not get 
chosen for transplants: “It is the struggle of conscientious doctors searching for criteria with 
which to address the obscene dilemma of selecting who will live. For many, time will run out 
before they get to the operating table. Not all can be treated, so desperate efforts are made to 
match the big waiting list with the small organ supply” (Sommerville, 1996, p. 499). 
One solution proposed is legislation that would designate everyone as an organ donor 
unless they specifically request otherwise (Brody, 2003; Smith, D., 2002). One lung recipient 
remarked that “If everyone willing to be a donor became one, there wouldn’t be an organ 
shortage” (Brody, 2003,  p. 5). In an effort by the state of Wisconsin to increase transplants, the 
State Senate passed a bill in January 2004 allowing a state income tax deduction of up to $10,000 
to cover expenses for donors. Similar legislation is pending in Indiana (Napolitano, 2004). 
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The Wait 
Status. When Valerie Vandervort was put on the waiting list, her doctor said, “We have 
to keep you well for two years” (Vandervort, 2002, para. 4). Because of the scarcity of available 
organs, the result is long waiting lists. Many people die while on the waiting list (488 in 2001 
according to UNOS data), or are taken off the list because they have become too sick for the 
surgery. As of March 19, 2004 there were 3,914 people on the waiting list for lung transplant, 
and the median wait time is approximately 2.3 years. The average patient waits over 24 months 
for a single lung, and approximately 36 months for two lungs (Hertz, 2001). There were 1,041 
lung transplant surgeries performed in the U.S. in 2002 (UNOS), which is approximately a third  
of the current waiting list. 
Currently, there is no priority listing for clinical status (Hertz, 2001; UNOS, 2003). 
Unlike waiting lists for other organs, such as heart or liver, which factor in the severity of the 
illness, the main selection criteria for lung transplant is who is at the top of the list. This first-
come, first-served policy may take away subjectivity in selecting who has the next surgery, but it 
makes the timing of referrals very important (Barzoloski-O’Connor, 2002). Hertz (2001) states 
that patients should be evaluated well ahead of the anticipated need if they are to survive in 
stable condition until the transplantation. 
Other primary factors affecting a patient’s wait for lung transplantation are blood type 
and body size for matching purposes (Barzoloski-O’Connor, 2002). Unfortunately, it is more 
difficult to get two perfect lungs from an organ donor because often one lung has been damaged 
or injured. Only 20% to 30% of donor lungs are available for transplant (Smith, S., 2002). 
Because of this, the wait for double lung is often longer than for single lung transplants 
(DeMarco, et al., 2001; Hertz, 2001). 
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Candidates for other transplants may have stopgap medical technologies to keep them 
alive until surgery – e.g., ventricular assist devices for cardiac patients, dialysis for kidneys 
(Kurz, 2001). Only oxygen is available for failing lungs, which makes the lengthy waiting list 
time for lung transplant even more precarious. 
Psychosocial Aspects. During the waiting period, the patient and their families/significant 
others have to deal with the uncertainties about whether and when a suitable donor organ will 
become available. Candidates are simultaneously faced with the prospects of preparing to live 
and preparing to die, and must cope with the stress of dying while hoping for a transplant. Not 
surprisingly, patients and families identify the waiting period as the most psychologically 
stressful part of the transplant experience. Anxiety disorders are more common in persons with 
end-stage lung disease, and lung disease, in particular, may have an etiologic relationship to 
anxiety disorders such as panic disorder (Bright & Craven, 1990; Dew, et al., 2002; Olbrisch, et. 
al., 2002).  
During this time, the person experiences worsening organ function and declining health. 
Patients are increasingly reliant on complicated medical technologies to keep them alive, and 
coping with increasingly complex medical regimens adds to the stress of the waiting period. 
Candidates may find themselves wishing for a donor and subsequently experiencing guilt when 
they reinterpret these thoughts as “wishing for another person’s death” (Bright & Craven, 1990). 
One recipient described his waiting experience by saying that his life “just sucked. It was 
so bad, it was to the point where I wasn’t sure that I wanted to go on like that. I was really 
wondering if it was worth it to me” (Festle, 2002, p. 75). Ted Tunison says in his online 
testimonial that he and his partner kept busy as possible, “to avoid thinking about the big IT” 
(Tunison, 2002, para. 12). In Ted’s case, once he got within three months of when the transplant 
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center determined he may be called, he was given a beeper in order to be available 24 hours a 
day. Ted related that getting the beeper was a “big deal” and the “wait becomes ever more 
serious. . .  It is impossible to describe the level of stress and anxiety you live with every day, as 
you wait and wait and wait” (para. 13). Laura Rothenberg summarized her agony of waiting by 
saying, “I realize that I am in a different time zone that very few are able to calculate” 
(Rothenberg, 2003, p. 77). 
This situation can place considerable strain on relationships within the family, and the 
primary players and relationships are vulnerable due to role changes and altered social 
relationships, because of the changes in their daily lives. Patients and families are likely to be 
dealing with new perceptions of self at this time (Dew, et al., 2002). Financial concerns may add 
to these strains. The transplant candidate is most likely unable to work due to declining health, 
and the primary caregiver (usually a spouse) may need to take substantial time off work. Many 
candidates and their families/caregivers have to relocate to be close to the transplant center, 
which can add psychosocial and financial stress. 
Even if a transplant takes place, patients face revising their life goals and plans. A 
concern of healthcare providers is that sometimes the patients have unrealistic expectations 
regarding posttransplant life (Dew, et al., 2002). 
This is a time of great psychological strain, which is why transplant centers place a high 
emphasis on the importance of patient and family involvement with support groups, because of 
the benefit of social supports and a supportive environment (Bright & Craven, 1990; Dew, et al., 
2002; Olbrisch, et. al., 2002). Patients are referred to both local and national support groups. 
Local groups should be facilitated by a transplant center moderator (Bright & Craven, 1990; 
Dew, et al., 2002), and may include correspondence by e-mail listservs. The most well known 
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national group is the Second Wind website, and can be contacted through the Internet 
(www.secondwindstl.org). In this way, people are no longer isolated individuals, but are 
connected with a larger community. A downside of the support groups is that participants often 
know someone who did not survive the wait, which may induce distress and grief (Dew, et al., 
2002; Festle, 2002). 
Ethical Issues. The increase of patients with long survival rates on the waiting list has a 
deleterious effect on survival for patients with poorer prognosis competing for the same organs 
(UNOS, 2003). This can also increase the average time to transplant, exacerbating problems 
associated with the organ shortage. Risk-based waiting list prioritizations are growing in 
popularity, and the UNOS Thoracic Committee is currently investigating a proposal to create a 
formula to determine priority on the lung transplant waiting list by risk of death and 
posttransplant survival (UNOS Annual Report, 2003). 
The tragic case of Jesica Santillan, the seventeen-year old girl who received a heart-lung 
transplant with the wrong blood type, received national media attention in February 2003 (Adler, 
et al., 2003). Not only did the surgeon and hospital come under fire for the grievous procedural 
error (hospital procedure has subsequently changed), but the hospital ethics committee’s decision 
to perform a second transplant has also been questioned. The committee justified their decision 
by stating that Jesica’s brain damage was “potentially reversible,” but she was declared brain 
dead and taken off life support two days later. The decision for a second operation is 
understandable as a compassionate response to the victim of an awful error, but in light of the 
scarcity of organs, it may have been unfair to the several thousand waiting list patients eligible 
for either a heart or a lung (Lustig, 2003). Although the UNOS has since implemented new 
procedural policies that specifically assign responsibilities for double-checking that blood types 
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match (Mecker, 2003; UNOS, 2003 Annual Report), the decision to retransplant in this case – 
and the ongoing issue of who gets priority – remains in question. 
The Call 
The candidate’s beeper or phone may ring at any hour. The voice on the other line will 
likely say, “This is a preliminary call. We may have a donor. How are you feeling?” If the 
candidate is ill, the call goes to the next matching person on the list. When the candidate receives 
confirmation, they grab their pre-packed bags and get to the transplant center as soon as possible 
- because for lung transplants, the organs remain viable for only about six hours (Barzoloski-
O’Connor, 2002). 
Perioperative Recovery 
Lung transplant recipients wake up from surgery hooked to a ventilator with their hands 
tied down so they can’t tear it out: 
[It was] just the most uncomfortable thing. You can’t eat. You can’t drink. You 
can’t talk. You can’t do anything. You’ve got a huge hose all the way down your 
throat into your lungs. And you can’t move. It’s hard to turn. That’s horrible. I 
wouldn’t wish it upon my worst enemy. (Festle, subject interview, 2002, p. 75) 
One recipient wrote a note to her nurse to ask if she was alive (Jewett, 2003). 
Another recipient who had difficulty getting off the ventilator and out of the intensive 
care unit said, “At one point during that time, I really thought, ‘Did I do the right thing? 
Should I have done this? I’m never going to get out of here’” (Festle, 2002, p. 82). 
Another says, “…it’s the hardest I ever…you’ll ever do in your life. It was painful, and it 
was hard, and it was a long road back” (p. 83). 
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Many are shocked at what they are expected to do in the hours or days after the surgery; 
e.g., get up and walk while still hooked to the chest tubes, being forced to cough despite searing 
pain (Festle, 2002, Jewett, 2003). Lungs are much more prone to injury than kidneys and livers, 
and unlike kidneys and livers, there’s no time to do tissue matching – the transplant must be done 
quickly (Key & Lindgren, 1999). This means that the potential for medical crisis is very high 
with lung transplantation. What is unique to the lungs is that it is the only organ system to 
interact directly with the external environment, hence the high risk of infections such as CMV 
(Barzoloski-O’Connor, 2002). A myriad of severe complications is possible at this early stage: 
acute rejection; risk of life-threatening infection, especially CMV; hallucinations and other 
psychiatric disorders, poor lung function requiring ventilator intubation; cardiovascular 
complications; and side effects from medications (Dew, et al., 2002; Festle, 2002; Greer, Kohn, 
Hasty & Henderson, 2000; Kurz & Cavanaugh, 2001; Smith, S., 2002).  
Most patients are released from the hospital in 7-14 days, but usually need to reside near 
the transplant center for 6-8 weeks for appointments and therapies before returning home (Smith, 
S., 2002). Despite the extensive regimen of toxic immunosuppressant drugs and their side 
effects, ongoing physical tests, rigorous physical therapy and excruciating pain, most recipients 
express a sense of relief and gratitude after surgery (Dew, et al., 2002; Festle, 2002). One 
recipient stated that even if they only got the month they already had, it would have been worth 
every second. A caregiver reflected, “It was the best of times and the worst of times” (Jones, 
2002, para.8). Most patients and families are extremely optimistic at this time, and express fewer 
concerns during this period than almost any other phase in the transplant process (Dew, et al., 
2002). Transplant recipient Ted Tunison (2002) shares his story on the Second Wind website: 
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About a week into my recovery a nurse came into my room to take my 
temperature, blood pressure, etc. She paused in mid-task, looked at me and asked 
if I wanted to listen to my new lungs. I had previously heard my old ones through 
a stethoscope, and they sounded like a cement mixer. I borrowed her stethoscope, 
but I could not hear a thing. She said to try again. I did, and still nothing. I was 
becoming frustrated. “What am I doing wrong; I don’t hear a damn thing.” “Be 
quiet, be very quiet and listen as carefully as you can,” she said. I did as told, and 
then I heard something. And I heard it again. Then again. And again. It was a 
gentle whoosh; so gentle it was difficult for my untrained ear to hear. Whoosh. 
Whoosh. Whoosh. My eighteen-year old lungs were giving me life with each 
breath that I took. Whoosh. Whoosh. I reached out, took her hand and started to 
tear. She looked at me and said, “That’s a mighty fine pair of lungs you have.” 
(para. 18) 
Posttransplant 
The two most important factors in early survival and recovery are compliance with the 
immunosuppressant medication regimen and adherence to physical therapy, especially regular 
aerobic exercise (Hertz, 2001; Smith, S., 2002). Patients generally take a year before they feel 
they are fully recovered (Dew, et al., 2002; Festle, 2002; Smith, S., 2002). Approximately 75% 
of lung transplant recipients (living and deceased donor recipients) survive the first year (UNOS, 
2003). 
Medical complications. An acute rejection episode (the body’s rejection of the “foreign 
invader” lung tissue) is most common in the first three months after surgery, and has been shown 
to be a major risk factor in the later development of chronic rejection or obliterative 
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bronchiolitis, especially when the acute rejection episodes are recurrent or severe. Prevention, 
early diagnosis, and treatment with immunosuppressant drugs optimize long and short-term 
outcomes (Hertz, 2001; Smith, S., 2002). However, “The high rate of acute rejection and 
subsequent obliterative bronchiolitis clearly indicates that current immunosuppression strategies 
are inadequate” (Stewart & Patterson, 2001. p. 204). 
The lung is the most common site of infection in all organ transplant recipients and 
infection is the leading cause of morbidity following lung transplantation; 65% of patients 
experience a lung infection (Smith, S., 2002). Cytomegalovirus (CMV) is the most common viral 
infection; CMV pneumonia being the most common in lung transplant recipients. These 
infections result from the suppression of the immune system brought on by immunosuppressant 
drugs. Antiinfective medications are used to help the body fight infections (Barzoloski-
O’Connor, 2002; DeMarco, et al., 2001; Smith, S., 2002).  
The mini-pharmacy of immunosuppressant therapy keeps the body from rejecting the 
new lungs, but the toll on the body is extensive. Heightened risk of infections, high blood 
pressure, diabetes, high cholesterol, possible development of cancer, reappearance of lung 
disease, osteoporosis, kidney disease, cataracts, mood swings and personality changes, 
gastrointestinal problems, muscle cramps and hand tremors are primary side effects (Barzoloski-
O’Connor, 2002; DeMarco, et al., 2001; Dew, et al., 2002; Festle, 2002; Henderson, 12/07-
14/2000; Hertz, 2001). The cost for these immunosuppressant and antiinfective medications is as 
much as $1000/day at first (Kurz & Cavanaugh, 2001) and around $2500 a month long-term 
(Barzoloski-O’Connor, 2002), so finding a way to cover this ever-increasing medical expense is 
likely to be a financial strain.  
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Psychosocial Aspects. Just as the lung transplant trades one set of medical problems for 
another, psychosocial aspects adjust after transplant as well.  
The early stages of recovery require intensive caregiver requirements, and the designation 
of a caregiver is a criteria for lung transplant eligibility (Bright & Craven, 1990; Hertz, 2001; 
Kurz & Cavanaugh, 2001). According to Kurz & Cavanaugh (2001) the caregiver is usually a 
spouse, and it is the couple, not just the patient, that adapts to the problems of life after 
transplant. A frequent refrain from caregivers/spouses and transplant recipients is that they did 
not feel prepared for, or were shocked by, the intensity of the medical regimen and roller coaster 
of medical crisis’ they would experience after surgery (Bright & Craven, 1990; Dew, et al., 
2002; Festle, 2002; Kurz & Cavanaugh, 2001; Olbrisch, et. al., 2002). 
Nevertheless, lung transplant recipients scored significantly better than candidates in 
studies that used self-rating scales to measure anxiety, depression, current state of health, and 
quality of life (Festle, 2002). The author acknowledges bias in these studies – data is missing 
from those post-operatives who are in poor health (and unable to take surveys) or have died. 
However, Festle’s QOL qualitative study of oral history interviews still reinforced these 
conclusions. A constant theme of these interviews was that recipients felt an exceptional sense of 
gratitude.  
“When asked about the current quality of their lives, the answer transplant recipients gave 
was usually a relative one, in direct comparison to how they had been doing before the 
transplant” (Festle, 2002, p.74). Most contrasted their pre- and post-operative lives in their 
answers. This is reflected elsewhere in Micheal Randolph’s Second Wind website entry: “This 
first year anniversary of a lung transplant, of which I almost did not survive, fills my soul, my 
body, my very being, with feelings of gratitude, joy and thanksgiving that are some times 
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overwhelming, indescribable, unbelievable. It has been a phenomenal year” (Randolph, M., 
2002, paragraph 1). 
Even those with serious, continuing health problems in Festle’s interviews (2002) said 
the transplant was worthwhile, and that their QOL is better than before the surgery. Perhaps this 
is because, despite the problems, the transplant gives people a marked improvement in their 
ability to breathe. In addition, all recipients interviewed knew that they had no chance other than 
a transplant in order to live. Festle acknowledges that because of their gratitude for getting a 
transplant, recipients may minimize the extent of their problems. Limbos, Chan & Kesten (1997) 
mention that when people are faced with near death situations, postevent QOL improves 
dramatically. Given the high death rate on the waiting list, the alternative (any time alive with 
transplantation) is considered quality time. 
Their gratitude extended to the donor and their families. Recipients experience mixed 
feelings of joy and relief, as well as sadness and anguish that their life came from the loss of 
another’s – which weighed heavily on their minds. Depending on transplant center policy and the 
donor family’s wishes, some recipients have the option of writing to the donor family. One 
recipient said he tried to write the letter for six and a half years: “How do you thank somebody 
for giving you your life? I’ve sat down ten times to write this letter, and I get very emotional and 
it’s too hard for me to write” (Festle, 2002, p. 79). Another recipient expressed his sadness and 
frustration that, because the donor’s family did not want to hear from recipients, he was unable to 
say thank you. 
An interesting phenomenon regarding receiving another person’s organs is demonstrated 
in Claire Sylvia’s book, “Change of Heart.” After a heart-lung transplant, she experienced 
changes in food cravings and her behavior, even the way she walked. Although she wasn’t told 
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her donor’s name, she says it was revealed to her in a dream. Her transplant coordinator 
confirmed the name was correct, and later, when meeting with her donor’s family, she 
discovered that her posttransplant food cravings and behaviors reflected those of her donor. 
Sylvia’s explanation was that cells have memory, so her body now contained the characteristics 
and personality of her donor. Although the evidence is anecdotal, other transplant patients have 
had similar experiences (Rosen, 1997). 
Recipients express a desire to express their gratitude for their transplant in tangible ways. 
Events honoring donor families, especially the Transplant Olympics (Festle, 2002; Sims M., 
2002; Sims R., 2002) are mentioned as significant. Others indicate having a “sense of purpose” 
and a desire to “pass along the gift” and that “I’ve been given so much that I want to give 
something back” (Festle, 2002, p. 80). 
According to Dew, et al. (2002), recipients and their families say it took longer than they 
expected to recover physically and emotionally from the transplant surgery and to adapt to the 
routine of medications and side effects. However, evidence suggests that posttransplant 
psychological adjustment may be less difficult for patients who wait for long periods. The list of 
psychosocial issues common to all organ transplant recipients are: coping with medical 
complications; psychological side effects of immunosuppressive drugs; managing a complex 
medical regimen of drugs, tests, diet, exercise and lifestyle restrictions; altering self-perceptions 
(less illness-focused); acceptance/dealing with someone’s loss of life when they regained 
his/hers; coping with financial issues (Depending on whether or not insurance is adequate to 
cover costs for treatment and medications, medical coverage can be a source of stress or comfort. 
[Kurz & Cavanaugh, 2001]). Olbrisch, et al. (2002) also mentions fear of organ rejection and 
infection as a main posttransplant stressor.  
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Unfortunately, psychological side effects of immunosuppressants include mood swings, 
sleep disorders, cognitive dysfunction, and hallucinations; and these side effects can mimic 
serious neuropsychiatric conditions. Laura Rothenberg’s memoir (Breathing for a Living, 2003) 
relays her struggle with severe anxiety attacks accompanied by uncontrollable shaking which 
required medical treatment. For months, her psychiatrist told her that she was experiencing post 
traumatic stress disorder (PTSD). However, when one of her immunosuppressant medications 
was changed, the anxiety attacks subsided. In general, the symptoms of these side effects tend to 
diminish over time, and there are newer drugs to help reduce these side effects (Olbrisch, et. al., 
2002). 
Clinically significant depression and anxiety disorders are more frequent during the first 
posttransplant year for lung transplantation.  Post traumatic stress disorder is second to 
depression in prevalence for first year transplant survivors (Dew, et al., 2002; Olbrisch, et. al., 
2002). One QOL study showed that, although overall QOL scores improved following 
transplant, women lung transplant recipients continued to have significant impairments, 
including those regarding sexuality and body satisfaction (Limbos, et al., 1997). 
 Evidence suggests that early intervention may deter the influence of psychological 
problems on the person’s health and well being in subsequent years. Also, early posttransplant 
psychological distress levels may influence medical compliance (Dew, et al., 2002), which tends 
to be demonstrated better early in recovery than later along (Olbrisch, et. al., 2002). 
In general, according to Dew, et al. (2002), psychological stress lessens as time goes on 
and people incorporate the transplant experience into their lives. However, “the development of 
new medical complications and loss of graft function may provoke psychosocial distress and 
even precipitate psychiatric disorders” (Dew, et al., 2002, p. 10). Unfortunately, psychosocial 
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issues in “the long-term years after transplantation have received relatively little attention” (Dew, 
et al., 2002, p. 12).  The importance of the transplant center continuing to maintain 
communication with the recipient and timely interventions with the recipient (by Internet if 
necessary) – as well as the need to identify appropriate interventions – is stressed. According to 
Limbos, et. al (1997), it is important to investigate the psychosocial impacts of lung 
transplantation to identify areas to target in the posttransplant period that may allow for an 
improved QOL. Since psychologic distress increases the likelihood of perceived physical 
limitations, timely identification and treatment of distress may help maximize QOL after lung 
transplantation (Dabbs, et al., 2003; Dew, et al., 2002). 
Long Range Outlook 
Status. Only heart-lung transplant has lower survival rate at three years (43%) than the 
lung-only transplant: 59% at three years, 46% at five years. By comparison, heart-alone 
transplant survival at three years is 77% (UNOS, 2003). However, a University of Wisconsin 
study showed that lung graft survival (with good function) was only 29% after two years in male 
donors-to-female recipients, compared with survival rates from 60-87% in all other patients (Key 
& Lindgren, 1999). Graft failure is usually associated with death of the recipient due to 
respiratory failure. This study’s findings appear to be unique to lung transplantation. 
Long term survival is limited by the development of obliterative bronchiolitis, also 
known as chronic rejection (Smith, S., 2002; Wunsch, 1999). It is generally irreversible (Hertz, 
2001). White patients experienced lower death rates and times to transplant than patients of other 
races on the lung waiting list. In 2001, the annual death rates per 1,000 patient years were 130, 
147 and 214 for white, African American and Asian patients, respectively (UNOS). 
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Outcomes and range of recovery can vary. Some recipients do not survive the surgery; 
other recipients have recovered to run marathons and engage in competitive bicycle racing 
(August & Faltermayer, 1996; Stanghelle, Koss, Bjortuft, & Geiran, 2000). Women’s Health 
Weekly (2002) states that successful pregnancy is possible, although lung transplant recipients 
are considered the highest risk group of transplant recipients. Most lung transplant centers 
advocate waiting two years after the surgery. 
Medical Advances. Medical breakthroughs continue to improve survival rates, and the 
literature is full of recent advancements in procedures, medications and health care, including the 
use of living donors in some conditions (Barclay, 2003; Grady, 2002; Henderson, 2000; Hertz, 
2001; Ko, 2001; Key & Lindgren, 1999, Smith, S., 2002; Stewart & Patterson, 2001). Another 
breakthrough is relaxed criteria for donor standards (Blood Weekly, 2003; Whiting, et al., 2003). 
The formation of a national collaborative, the Organ Donation Breakthrough Collaborative, will 
test best practices in increasing donor consent rates, and a national campaign to increase minority 
donations (UNOS news releases at http://www.optn.org/news/) should contribute to the 
availability of organs. Surgeons at the University of Pittsburgh Medical Center have developed 
an unconventional post-transplant protocol that uses significantly less antirejection drugs. The 
result is much less risk for complications/side effects associated with high levels of 
immunosuppression, which is common in lung recipients (Immunotherapy Weekly, 2003; 
Waldholz, 2003). As survival rates improve, it is expected that the number of lung transplant 
survivors in rehabilitation will increase. 
Employment 
Employment is an important aspect of the reestablishment of a transplant recipient’s 
identity, self-esteem and quality of life (Olbrisch, et. al., 2002; Carter, Winsett, Rager & 
 
27 
Hathaway, 2000). However, even with physical rehabilitation, which can be a long and grueling 
process, recipients may face functional limitations and medical restrictions in their activities. 
Recent studies have demonstrated that although more than 62% of all transplant patients are able 
to resume work within 9-12 months posttransplant, less than 50% are returning to work. 
Unemployment nationally among all transplant recipients is roughly 80% (Carter et al., 2000). 
Although the Ochsner Transplant Clinic in New Orleans claims that half of all their lung 
transplant recipients have returns to gainful employment, 
(http://www.ochsner.org/transplant/lung_evaluation.html), there is no supporting documentation 
or mention of a return-to-work program. From a cursory review of lung transplant center’s Web 
sites, it appears that the medical centers’ primary method of addressing post-transplant 
employment is to provide a description of state Rehabilitation Services and the Americans with 
Disabilities Act as a referral to resources. An excellent example is the USC Web site: 
http://www.usctransplant.org/lung/rehabilitation.html.  
An exception is the Vanderbilt Medical Center, which has a Return-to-Work program 
directed by a Certified Vocational Evaluator. Working in coordination with the State Division of 
Rehabilitation Services, the program offers a range of free services from career interest testing to 
job retraining. The Transplant Return-to-Work program is designed to find solutions to the low 
employment rates among transplant patients. Since its inception, the program has had over 400 
referrals, 300 participants, and 125 participants have returned to previous employers or found 
new jobs through the program. Others have become involved in career retraining through 
Tennessee State Rehabilitation Services (http://www.mc.vanderbilt.edu/transplant/transvoc.htm). 
This author was only able to discover two references in the literature that specifically 
address lung transplant recipient’s return-to-work (Festle, 2002; Paris, et. al, 1998). The Paris 
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study found that 38% of lung transplant recipients who were medically able to work remained 
unemployed. Only 22% of 99 recipients were employed after transplant, 29% were disabled and 
10% were retired.  Festle’s summary is that “despite improvements in QOL and function, only a 
small percentage of lung transplant recipients returned to work” (p.71). Given the deconditioning 
and deteriorating health associated with sitting on a long waiting list prior to surgery, extensive 
complications associated with lung transplant surgery, and limited life expectancy, it is likely 
that lung transplant recipients’ employment rates would be at least the same, if not lower, than 
other recipients. During a conversation with Dr. Marshall Hertz, Director of the lung transplant 
program at Fairview University Medical Center in Minneapolis, (personal communication  
January 19, 2004), his observation was that most recipients choose not to work, although he 
remarked he didn’t know why. 
The first year post-transplant has the potential for medical crises, and well as many clinic 
visits, physical therapy, etc., making it difficult to incorporate medical and work schedules. 
Recipients who have been out of work for long periods will tend to have difficulty in returning to 
work. Depending on the work environment, return to work may pose potential health risks to 
lung transplant recipients (Couture, 2001). Potential barriers for all organ recipients’ return to 
work include: a change in the recipient’s life priorities, hiring discrimination on the basis of 
medical history, poor economic conditions, health insurance availability or restrictive cost, 
limited education or work skills, or the recipient’s perception that these obstacles are 
insurmountable (Carter, et al., 2000; Couture, 2001). Also, “remaining on disability after the 
transplant would have been acceptable to all recipients because of their lack of knowledge about 
how to re-enter the workforce” (Carter, p. 207). 
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The solution proposed in the Carter et al. (2000) study was to incorporate an employment 
specialist on staff at a kidney/liver/pancreas transplant center as a liaison to the state Vocational 
Rehabilitation (VR) department. The employment specialist provides expertise on the unique 
problems organ transplant recipients face, while the VR counselor serves as the guide through 
the landscape of a sometimes confusing process. Another benefit of adding an advocate for 
employment to the transplant center is a “shift in the thinking and approach to care from the sick 
role to one of rehabilitation and from reactive to proactive” (Carter, et al., 2000, p. 206). This 
change in attitude is intended to assist in empowering transplant recipients to feel as if they can 
truly resume a normal life. Study findings showed that since the employment specialist era, 
posttransplant employment rates improved significantly for recipients who were both employed 
and unemployed prior to surgery. Adding an employment specialist to the transplant center 
appears to provide a bridge for the transition from being a patient into vocational rehabilitation: 
“The employment program has allowed us to think beyond the disease to recovery” (Carter, et 
al., p. 207). 
Uniqueness of Lung Transplant 
Organ Transplant Commonalties 
Lung transplantation has much in common with other solid organ transplantation: gravely 
deteriorating health; evaluation of eligibility for surgery; waiting for organ donation/match; 
someone almost always has to die; anxiety and depression; major surgery, hospitalization and 
rehabilitation; and the need to take immunosuppressant medications for the remainder of one’s 
life. 
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Issues unique to lung transplantation  
Medical: Supplemental oxygen is usually required 24 hours a day for pre-operative 
persons; the wait is extremely long (only heart-lung median wait is longer at 934 days; heart-
only is 307 days [UNOS, 2003]); poor odds of getting a lung in time; the sensitivity and viability 
of the organ; the high percentage of medical risks involved, including high risk of infection; and 
limited life expectancy compared to other transplants.  
Psychosocial: Anxiety is highest in this population followed by PTSD and depression. 
End-stage lung disease, and lung disease, in particular, may have an etiologic relationship to 
anxiety disorders such as panic disorder. 
Ethical: Because of severe organ shortage, the first-come, first-served policy extends the 
waiting list to the point that the majority of candidates, regardless of how critically ill they are, 
may never get a transplant. Eligibility determination is becoming increasingly controversial. 
Vocational: The primary uniqueness here is the lack of data. What little data exists 
suggests that employment rates may be at least equal to, if not lower than, other transplant 
recipients’ rates. Also, it is possible that employment may not be a high priority in this 
population. 
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CHAPTER 4: SUMMARY & CONCLUSIONS 
Summary 
The literature in this review begins to tell of the arduous, harrowing, painful, exhilarating, 
traumatic, life-and-death experience of lung transplant recipients.  
The majority of lung transplantation literature is geared towards and addresses the 
medical crisis/triage aspect of keeping patients alive and psychologically capable – and 
understandably so, given the risks involved, inherent stressors and limited life expectancy. 
However, there is very little qualitative research regarding lung transplant recipients, and there is 
an even more obvious lack of research on the subject of employment (quantitative and 
qualitative) in this population. What research exists demonstrates that, despite a myriad of 
complications, lung transplant recipients report an improvement in their quality of life after 
surgery. However, it appears that the majority of recipients do not return to work, even if 
medically capable. Psychosocial issues are seen as significantly impacting this population, and 
the importance of addressing these issues as soon as they arise in order to maximize quality of 
life posttransplant is stressed repeatedly in the literature. 
There is very little discussion of lung transplant recipient’s posttransplant values, 
priorities, and perspectives regarding employment in the literature reviewed. Most of the 
literature that was qualitative in nature and/or discussed employment was anecdotal, memoir-
type material. Any conclusions on employment issues can only be inferred at this point. 
Conclusions 
Some of the possibilities for the lack of research may be: This is a relatively new field 
and the primary focus is on medical issues and survival, recipients have relatively low survival 
rates and limited life expectancy, 57% of recipients from 2001-2003 were ages 50-64 and are 
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nearing retirement age, and accessing the medical community to administer surveys is difficult. 
However, there are people who survive surgery, and even if it is for only three to five years, they 
deserve the best rehabilitative services we can provide. Therefore, the more information 
gathered, and the more we learn and understand about the individual’s experience, the better 
equipped medical and rehabilitation providers are to provide quality care and services. 
The majority of lung transplantation research is medically based, and although it is 
necessary and informative, it is only the beginning. Gaining a full appreciation for what these 
people have endured and what this experience means to them is an important part of the 
landscape for rehabilitation. Therefore, there is a need for research to supplement the medical 
data with more qualitative, psychosocial quality of life studies that incorporate the aspect of 
vocational rehabilitation – it is sorely missing. 
For this author, the medical background lays an essential foundation of knowledge for 
serving this population. However, it is the qualitative, anecdotal material that proved to be the 
most personally compelling – for this is what infuses humanity into the statistics. In conclusion, 
here is a poem written by Laura Rothenberg’s friend, Diane Sawyer, regarding Laura’s double 
lung transplant surgery: 
The transplant was an education (like a crash course in medical school). 
It was hope and prayer all braided into one. 
It was joy, then a whiplash of worry. 
Finally, feeling like a parachute opened on a free fall. 
And most of all, it was Laura, full bravery, full passion, full poetry. 
It was a reminder that life doesn’t let us choose. But oh how it lets us love.  
(Rothenberg, 2003, p. 216) 
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CHAPTER 5: RECOMMENDATIONS FOR FUTURE RESEARCH  
Employment Statistics 
 There is a serious lack of, and need for, employment statistics data for lung transplant 
recipients. One research study from 1998 is simply not enough information. 
Qualitative Research 
Qualitative research attempts to understand the world from the subjects’ point of view, to 
unfold the meaning of people’s experiences (Kvale, 1996). According to Meg Sewell’s online 
text, (2001), qualitative interviewing is most useful for exploring individual differences between 
participants’ experiences and outcomes, and evaluating programs that are seen as dynamic or 
evolving. The primary advantages of using qualitative interviewing (open-ended questions) are:  
• Allows the participant to describe what is meaningful to him or her using his or her 
own words rather than being restricted to predetermined categories; thus participants 
may feel more relaxed and candid,  
• Provides high credibility and face validity; results “ring true” to participants and 
make intuitive sense to lay audiences (Sewell, p. 3). 
There is not much qualitative research on lung transplant recipients. There is none that 
specifically investigates transplant recipient’s posttransplant values, priorities, and perspectives 
regarding employment. As survival rates continue to improve, qualitative research will be an 
important factor in this evolving field, and will benefit professionals in health care and 
rehabilitation – as well as the individuals with their family and friends. 
Suggested survey 
The following suggested survey (see Appendix A) for lung transplant recipients is a 
semi-structured interview that would collect primarily qualitative data. The survey intent is to 
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elicit responses that accurately represent the person’s point of view about their experience of 
surviving lung transplant. The survey is a combination of qualitative and quantitative data. 
The nature of the data is expected to provide a more in-depth understanding of the 
experience of those who have survived lung transplant surgery than what currently exists. A 
primary intent is to capture the person’s posttransplant values, priorities, and perspectives 
regarding employment. 
Some examples of the open-ended interview questions: “How has your lung condition 
impacted your life?” “How have your life priorities and values shifted or changed since your 
surgery?” “What do you see as your barriers to employment?” 
Some questions require responses on a Likert-type scale rating. The Likert scale can be 
modified to provide more specific replies to questions such as, “Where does employment fit into 
your priorities? – Very Important/Somewhat Important/Not Very Important/Not Important at 
All.” The purpose for reducing the range of responses on the scale is to avoid the tendency of 
respondents to gravitate toward the center (middle response), thus encouraging respondents to 
make a decisive response one way or the other. Ideally, this modification will provide more 
“truthful” and valid data.  
In addition, some closed-ended questions will be asked. Examples of closed-ended 
questions are: “Are you unemployed/employed full time/employed part time?” “If you are 
unemployed, do you think it’s likely you will be employed?” “If you are unemployed, do you 
wish to be employed?” and, “If you had to do it all over again, would you make the same 
decision to undergo the transplant surgery?”  
It is also suggested that care providers complete a short, open-ended survey (See 
Appendix B) that addresses some of the same themes from the patient’s surveys; e.g., “What do 
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you see as the most critical issues facing people posttransplant?” “In your opinion, what is the 
vocational outlook for people with postoperative transplant?” 
Return to Work Programs 
It is recommended that a study be conducted of all lung transplant medical centers to see which 
incorporate Return-to-Work programs (such as the Vanderbilt Medical Center), and perform an 
in-depth analysis of those that do exist in order to yield a “best practices” summary of the most 
successful programs. Ideally, this in-depth research would then yield a pilot program that could 
be adapted to other transplant centers in conjunction with local Departments of Rehabilitation 
Services. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
References 
Adler, J., Campo-Flores, A., Lacy, B.A., Smalley, S., Scelfo, J., Raymond, J., et al. (2003). A 
Tragic Error. Newsweek. 141(9):20. 
August, L., & Faltermayer, C. (1996). Local heroes. Time. 148(5):24. 
Barclay, L. (2003). For Posttransplant Immunosuppression, Less Is More: A Newsmaker 
Interview With Thomas E. Tarzl, MD, PhD. [Electronic version]. Lancet 361:1502-1510. 
Barzoloski-O’Connor, B. (2002). Waiting to Inhale: Lung Transplants Offer New Breath of Life 
for Patients. Nursing Spectrum. 3(1).  
Bold approach has lung transplant patients taking fewer antirejection drugs. (2003). 
Immunotherapy Weekly. June 25, 2003. p.84. Retrieved 03/29/04 from EBSCO host 
database. 
Bright, J., & Craven, J. (1990). Assessment and management of psychosocial stress in lung 
transplant. Health & Social Work. 15(2):125-132. 
Brody, J. (2003). Beating the Odds, With New Lungs and a Zeal for Life: A Conversation with 
Charlie Tolchin. New York Times. 01/14/2003:F5. 
Carter, J., Winsett, R., Rager, D., & Hathaway, D., University of Tennessee, Memphis; Rager 
Employment Services, Beaverton, Ore. (2000). A Center-Based Approach to a Transplant 
Employment Program. [Electronic version]. Prog Transplant. 10(4):204-208.  
Couture, K. (2001). The Lung Transplantation Handbook. (2nd ed.) Victoria, British Columbia: 
Trafford. 
Dabbs, A., Dew, M., Stilley, C., Manzetti, J., Zullo, T., McCurry, K., et al. (2003). Psychosocial 
vulnerability, physical symptoms and physical impairment after lung and heart-lung 
 
37 
transplantation. [Electronic version]. Journal of Heart and Lung Transplantation 
22(11):1268-1275 Nov 2003 
DeMarco, T., Frost, A., Garrity, E., Hertz, M., Madsen, J., Maurer, J., et al. (2001). Getting a 
New Lung: Facts About Lung Transplants. [Electronic version]. Mount Laurel, NJ: 
American Society of Transplantation. 
Dew, M., Manzetti, Goycoolea, J., Lee, A., Zomak, R., Vensak, J., et al. (2002). Psychosocial 
Aspects of Transplantation. [Electronic text]. In Sharon Smith (Ed.).Organ 
Transplantation: Concepts, Issues, Practice, and Outcomes (Chapter 8). Retrieved 
06/23/03 at http://www.medscape.com/viewarticle/436541 
Festle, M. (2002). Qualifying the Quantifying: Assessing the Quality of Life of Lung Transplant 
Recipients. Oral History Review. 29(1):59-86. 
First double-lung transplant recipient dies. (2001). Canadian Medical Association Journal 
164(11):1610. 
Grady, D. (2002). Obituary: Kimberly Miles, 33, Recipient In a Rare Lung Transplant. New York 
Times. 05/16/2002:B.1. 
Greer, M., Kohn, C., Hasty, S., & Henderson, C.W. (2002). Viral infections often trigger 
bronchiolitic rejection lung graft rejection. [Electronic version]. TB & Outbreaks Week. 
07/16/2002:11. 
Heart-lung recipient who had disability dies. (1997, May 26). New York Times 146(50804):11. 
Henderson, C. (2000). Drug Delivery: Aerosol Hits Target in Lung Transplant Patients. Blood 
Weekly. 09/07/2000:5. Retrieved 03/20/03 from EBSCOhost database. 
Henderson, C. (2000). Flu Vaccine Not Effective in Lung Transplant Patients. Blood Weekly. 
12/07/2000-12/14/2000:22. Retrieved 03/20/03 from EBSCOhost database. 
 
38 
Hertz, M. (2001). Manual of Lung Transplant Medical Care (2nd ed). Minneapolis, MN: 
Fairview Publications. 
Jauhar, S. (2003). When Doctors Slam the Door. New York Times Magazine 152(52424):32-35. 
Jewett, S. (2003). I call my new lung Tina: inspiration from a transplant survivor (2nd ed). 
Camarillo, CA: Water Signs Pub. 
Jones, R. (2002). Miracles in Progress. Member Stories from Second Wind website. Retrieved 
6/26/03 at http://www.secondwindstl.org./ritajones.html  
Key, S. & Lindgren, M. (1999). Differences in Smoking and Lung Transplant Outcomes 
Explored. Women’s Health Weekly. 05/10/1999:12. 
Ko, M. (2001). A second life for Amy. Report/Newsmagazine (Alberta Edition) 28(9):38-40. 
Kurz, J. (2001). Experiences of well spouses after lung transplantation. Journal of Advanced 
Nursing 24(4):493-500. 
Kurz, J. & Cavanaugh, J. (2001). A Qualitative Study of Stress and Coping Strategies Used By 
Well Spouses of Lung Transplant Candidates. Families, Systems & Health: The Journal 
of Collaborative Family HealthCare. 10(2). 
Kvale, S. (1996). Inter Views: An introduction to qualitative research interviewing. Thousand 
Oaks, CA: Sage. 
Lau C., & Patterson, G. (2003). Current status of lung transplantation. [Electronic version]. 
European Respiratory Journal. 22:57S-64S Suppl 47 November 2003. 
Limbos, M., Chan, C.,  & Kesten, S. (1997, November). Quality of Life in Female Lung 
Transplant Candidates and Recipients. [Electronic version]. Chest 112(5).   
 
39 
Liou, T. G., Adler, F. R., Cahill, B. C., FitzSimmons, S. C., Huang, D., Hibbs, J. R., et al. 
(2001). Survival Effect of Lung Transplantation Among Patients with Cystic Fibrosis. 
JAMA 286(21):2683. 
Lustig, A. (2003). Death & Transplants. [Electronic version]. Commonweal 130(7). 
Maurer, J. (2001). Patient Selection for Lung Transplantation. JAMA 286(21):2720-21. 
Mecker, L. (2003). New Transplant Policies After Girl Dies. [Electronic version]. HBV Research 
Announcement List. Sat, 28 Jun 2003 09:29:17 –0400. Retrieved 03/20/04 at 
http://archive.mail-list.com/hbv_research/msg05348.html 
Modified lung donor standards increase donor pool, decrease mortality. (2003). [Electronic 
version]. Blood Weekly. 11/27/03, p.40-41. Retrieved 3/20/04 from EBSCOhost Web 
database. 
Napolitano, J. (2004). Wisconsin Senate Approves Tax Deduction for Organ Donors. [Electronic 
version]. New York Times. 01/23/2004. 
Newman, P. (1999). Two dramatic tales of personal survival. Maclean’s. 112(7):48. 
Olbrisch, M. E., Benedict, S. M., Ashe, K., & Levenson, J. L. (2002). Psychological Assessment 
and Care of Organ Transplant Patients. Journal of Consulting & Clinical Psychology 
70(3):771-785. 
Paris, W., Diercks, M., Bright, J., Zamora, M., Kesten, S., Scavuzzo, M., et al. (1998). Return to 
work after lung transplantation. Journal of Heart and Lung Transplant. 17(4). 
Randolph, M. (2002). Monday of Holy Week 2003. Member Stories from Second Wind website. 
Retrieved 6/26/03 at http://www.secondwindstl.org/mpggr.html 
Rosen, M. (1997). Heart…and soul? Biography. 1(11):66-70. 
Rothenberg, L. (2003). Breathing for a living: a memoir. New York, NY: Hyperion. 
 
40 
Sewell, M. (2001). The Use of Qualitative Interviews in Evaluation. [Electronic version]. An 
online guide posted by the University of Arizona, Tucson in collaboration with the 
Children, Youth and Families Education and Research Network (CYFERnet). Retrieved 
08/12/2002 at http://ag.arizona.edu/fcr/fs/cyfar/Intervu5.htm 
Sims, M. (2002). Transplant Games. Member Stories from Second Wind website. Retrieved 
6/26/03 at http://www.secondwindstl.org./margaretsims.html  
Sims, R. (2002). Transplant Games Experience. Member Stories from Second Wind website. 
Retrieved 6/26/03 at http://www.secondwindstl.org./randysims.html 
Smith, D. (2002). Battling Failing Health, in Her Own Words. New York Times. 08/05/2002:E1. 
Smith, S. (Ed.). (2002). Organ Transplantation: Concepts, Issues, Practice, and Outcomes. 
[Electronic text]. Retrieved 06/23/03 at 
http://www.medscape.com/viewpublication/704_about 
Sommerville, A. (1996). A view from the back of the queue. British Medical Journal. 
313(7055):499. 
Stanghelle, J. K., Koss, J. O., Bjortuft, O., & Geiran, O.  (2000). Marathon with cystic fibrosis 
and bilateral lung transplant. Scandinavian Journal of Medicine & Science in Sports. 
10(1):42-46. 
Stewart, K., & Patterson, G. (2001). Current Trends in Lung Transplantation. American Journal 
of Transplant. 1(3):204-10. 
Tomb, D. (2002). A Reluctant Transplant. Member Stories from Second Wind website. 
Retrieved 6/26/03 at http://www.secondwindstl.org./jimdemare.html  
Tunison, T. (2002). “Mighty” and “Fine” – My Transplant Story. Member Stories from Second 
Wind website. Retrieved 6/26/03 at http://www.secondwindstl.org./tedtunison.html  
 
41 
United Network for Organ Sharing. (2003). Annual Report of the U.S. Scientific Registry of 
Transplant Recipients and the Organ Procurement and Transplantation Network: 
Chapter VIII-Thoracic Organ Transplantation. [Electronic version]. Rockville, MD and 
Richmond, VA: HHS/HRSA/OSP/DOT and UNOS.  
 United Network for Organ Sharing. (2002). Annual Report of the U.S. Scientific Registry of 
Transplant Recipients and the Organ Procurement and Transplantation Network: 
Chapter 8 -Thoracic Organ Transplantation. [Electronic version]. Rockville, MD and 
Richmond, VA: HHS/HRSA/OSP/DOT and UNOS.  
Vandervort, V. (2002). My Tremendous Journey. Member Stories from Second Wind website. 
Retrieved 6/26/03 at http://www.secondwindstl.org./valerievandervort.html  
Victory for the disabled. Mclean’s (1995). 4/24/95; 108(17):25. 
Waldholz, M. (2003). Transplant pioneer Rejects Approach He Helped Create. [Electronic 
version]. Wall Street Journal. 06/02/03. 241(106):A1. 
Whiting, D., Banerji, A., Ross, D., Levine, M., Shpiner, R., Lackey S., et al. (2003). 
Liberalization of Donor Criteria in Lung Transplantation. [Electronic version]. American 
Surgeon. 61(10):909. 
Women’s Health Weekly. (2002). Heart, heart-lung and lung transplant recipients can have 
successful pregnancies. [Electronic version]. 10/03/2002:18. 
Wunsch, H. (1999). Lung transplantation still hampered by chronic rejection. Lancet. 
354(9186):1270. 
 
 
 
 
42 
Appendix A 
Lung Transplant Recipient Survey 
Gender (Check or “X”one):  
 Male 
 Female 
     
Please indicate the Age range that applies: 
 18-34 
 35-49 
 50-64 
 Over 65 
 
Please indicate your Race/Ethnicity:         
 
Employment Status (Check or “X” one):    
 Unemployed 
 Employed Part Time 
 Employed Full Time 
 
Disability Status (Please indicate the one that best applies): 
 I currently qualify for disability benefits 
 I do NOT qualify for disability benefits 
 I have applied for disability benefits and am awaiting a response 
 Don’t know 
 
How are your medical costs being paid? 
 Self (no insurance coverage) 
 Private insurance 
 Public (Medicare/Medicaid) 
 
If your medical coverage is through private insurance, is it:  
 Provided by Employer 
 Spouse or partner’s family coverage 
 
What are your estimated OUT OF POCKET expenses (what you pay) per year? 
 
Do you have any comments about your medical coverage?  
  
How long were you on the waiting list for a transplant?      
 
How long ago was your surgery?         
 
Check one:   
 One lung 
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 Both lungs 
 
How has your lung condition impacted your life? 
 
Vocationally: 
Emotionally: 
Socially: 
Accessibility issues: 
 
Have your life priorities and values shifted or changed since your surgery? 
 Yes 
 No 
  
If so, what has changed and how? 
 
What is most important to you now? 
 
Where does employment fit into your priorities? 
 Very Important 
 Somewhat Important 
 Not Very Important 
 Not Important at All 
Please list your top three most critical needs: 
 
FIRST critical need: 
How well do you think this is being addressed? 
 Very Well 
 Well 
 Hardly 
 Ignored 
   
SECOND critical need:  
How well do you think this is being addressed? 
  Very Well 
 Well 
 Hardly 
 Ignored 
   
THIRD critical need:  
How well do you think this is being addressed? 
 Very Well 
 Well 
 Hardly 
 Ignored 
 
What is the most helpful service you are receiving now with regard to your lung condition? 
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Who do you see as your primary sources of support? (Some examples are spouse, family, 
friends, other transplant recipients and their families, your faith community, medical staff or 
anyone that you find helpful.) 
 
Who is your primary caregiver at present? 
 Spouse/partner 
 Family member (Please indicate relationship - mother, brother, etc.) 
  
 Other (please indicate) 
If you are unemployed, do you think it’s likely you will be employed? 
 Yes 
 No 
 
If you are unemployed, do you wish to be employed? 
 Yes 
 No 
 
Did you receive any vocational services or vocational counseling from the transplant center? 
 Yes 
 No 
 
Have you sought help for finding employment from state vocational rehabilitation services? 
 Yes, and I am receiving services 
 Yes, but I did not qualify for services 
 No 
 
If you could get free help for finding employment, would you? 
 Yes 
 No 
 
What do you see as your barriers to employment? 
 
What are your limitations?  
 
What are your possibilities? 
 
If you had to do it all over again, would you make the same decision to undergo lung transplant 
surgery? 
 
What other comments do you have? 
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Appendix B 
 
Care Provider for Lung Transplant recipient 
 
 
Your Position/Title:            
 
Length of time in transplant field:          
 
What do you see as the most critical issues facing people with post-operative lung transplant? 
 
In your opinion, what is the vocational outlook for people with post-operative lung transplant?  
 
Does your transplant center provide vocational counseling or services of any kind? 
 
If Yes, please explain: 
 
What are the limitations for persons with post-operative lung transplant? 
 
What are the possibilities for persons with post-operative lung transplant? 
 
What other comments do you have?  
 
 
